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Objective: Subjects with symptomatic peripheral artery disease (PAD) have an elevated prevalence of carotid stenosis and
of silent myocardial ischaemia. As such, clinical guidelines advocate the detection of sub-clinical vascular disease in this
population. However, the prevalence of occult vascular disease in asymptomatic patients with a low ankle-brachial index
(ABI) has not been previously evaluated.
Methods: Cross-sectional study in five primary care centres for patients’ selection and two University Hospitals for further
assessment. Subjects were 1070 asymptomatic individuals between 60 and 80 years of age with at least two cardiovascular
risk factors, selected for ankle-brachial index measurement. Eighty five subjects with an ABI <0.9 and an equal number
of controls, matched for age, gender, diabetes, and smoking habit, and with a normal ABI, were referred to the Hospital
for carotid ultrasound and exercise stress tests (EST). Main outcome measures were prevalence of a carotid stenosis>50%
and an abnormal EST.
Results: The prevalence of a low ABI in the overall population was 9.1%. A carotid stenosis >50% was detected in 14.3%
of the subjects with a low ABI and in 4.7% of the control subjects (Odds Ratio [OR]: 3.37; 95% Confidence Interval [CI]:
1.04-10.93, P  .033). The prevalence of a positive EST test was 16.2% in those with a low ABI and 10.5% in control
subjects (OR: 1.65; 95% CI: 0.63-4.29, P  .309). These prevalences were higher in older subjects, in those with
hypertension or diabetes, or in those with dyslipidemia.
Conclusion: Our results indicate that in high-risk asymptomatic subjects >60 years of age, the presence of an ABI <0.9
identifies a subgroup of the population with an increased prevalence of carotid stenosis and of silent myocardial ischemia
and, as such, are candidates for closer follow-up. (J Vasc Surg 2009;49:104-8.)Subjects with symptomatic peripheral artery disease
(PAD) have an elevated rate of cardiovascular morbidity
and mortality1 and, as such, they are candidates for inten-
sive treatment of their cardiovascular risk factors.2 Due to
this high risk, some authors and consensus documents have
recommended the systematic search for occult coronary
and cerebrovascular disease in this population.3-7
Asymptomatic subjects with PAD also have an elevated
risk of cardiovascular disease which, in some studies, paral-
lels that of symptomatic individuals.8 For that reason, and
in order to improve risk stratification, ankle-brachial index
(ABI) measurement has been recommended in subjects of
intermediate risk.2,5 This has come to a widespread use of
ABI measurement in daily clinical practice and to the identi-
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104fication of a high number of asymptomatic individuals with
PAD. However, the prevalence of occult coronary and cere-
brovascular disease in this asymptomatic population has not
been investigated previously and, for that reason, specific
recommendations on the screening for carotid stenosis or
coronary artery disease cannot be made at present.
The objective of the present study was to evaluate the
prevalence of significant carotid artery disease and of silent
myocardial ischemia in subjects 60 years of age with
asymptomatic PAD and without known cardiovascular dis-
ease. We compared these patients with a control group,
matched for age, gender, diabetes, and smoking habit and
with a normal ABI.
PATIENTS AND METHODS
Five health-care centers, two in Madrid and three in
Santiago de Compostela (Spain), were selected for the
study. Between January 2007 and June 2007, subjects
between 60 and 80 years of age and with at least two
cardiovascular risk factors (being male, current smoker,
hypertension, diabetes, or low density lipoprotein (LDL)-
cholesterol 4.1 mmol/L) were invited to participate.
Those individuals who had a previous diagnosis of coro-
nary, cerebrovascular, or PAD, or those who were being
investigated because of chest pain, clinical manifestations
compatible with stroke, or transient ischaemic attack (TIA)
or who had clinical symptoms suggestive of typical inter-
ipopro
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patients with atrial fibrillation or receiving treatment with
drugs that could alter the basal ST segment such as digoxin, or
who were incapable of understanding the protocol and of
providing informed consent to participation. On recruitment,
all subjects had a complete clinical history and physical exam-
ination that included height, weight, and blood pressuremea-
surement. A blood sample was taken for analysis of glucose,
total cholesterol, LDL-cholesterol, high density lipoprotein
(HDL)-cholesterol, and total triglycerides.
The diagnosis of hypertension required a blood pres-
sure140/90mmHg,130/80mmHg for subjects with
diabetes or chronic kidney disease, or being on treatment
with anti-hypertensive drugs. The diagnosis of diabetes was
established in accordance with the criteria of the American
Diabetes Association.9
All subjects had an ABI measurement performed with a
bi-directional portable echo-Doppler of 8 MHz (Minidop-
pler HADECO ES-100, Kawasaki, Japan) and a calibrated
mercury sphygmomanometer. The systolic blood pressure
(SBP) was measured in the posterior tibial and pedal arter-
ies of both lower limbs and the brachial artery of both upper
limbs. The value of the ABI for each limb was calculated
dividing the greater systolic blood pressure (SBP) obtained
in each limb by the SBP of whichever was the higher in the
upper limbs. The lowest value obtained was considered the
ABI for that individual.
All patients with a low ABI (0.9) and one control
subject for each patient (1:1) matched for age (within five
years), gender, diabetes, and smoking status were invited to
continue in the study in one of the referral hospitals (Hos-
pital Carlos III de Madrid or the Hospital Universitario de
Santiago de Compostela) in which a carotid duplex scan
and a EST were performed in all participants.
Carotid duplex protocol. Carotid ultrasound was
evaluated with an Aplio 50 ultrasound scanner (Toshiba
Medical Systems, Tokyo, Japan) with a PLT-704 AT trans-
ducer of 7.5 MHz. The patient was explored in the supine
Table I. Characteristics of the study population (n  107
ankle-brachial index
Characteristic Total Low A
Gender; % males 52.9
Age; years 66.7 (6.5)
Smokers or ex-smokers; % 26.1
Hypertension: % 62.4
Diabetes; % 35.2
BMI; kg/m2 29.3 (4.3)
SBP; mmHg 146 (20)
DBP; mmHg 81 (10)
LDL-cholesterol; mmol/L 3.56 (.90)
HDL-cholesterol; mmol/L 1.37 (.33)
Triglycerides; mmol/L 1.45 (.88)
BP lowering drugs; % 49.5
Lipid lowering drugs; % 37.1
BMI, body mass index; DBP, diastolic blood pressure; HDL, high density ldecubitus position with the head rotated away from the sidebeing evaluated. The evaluation of carotid plaques (mode
B) was performed in longitudinal and transversal planes at
the level of the common, bulb, and internal carotid. The
presence of a plaque was defined as a thickening of the
arterial wall 1.5 mm.10 Two measurements (longitudi-
nal/transversal) were made to determine the grade of ste-
nosis at the point of greater acceleration, applying the
criteria of Grant et al.11 Stenosis 50% was defined as a
peak systolic velocity in the internal carotid artery 125
cm/s, an end-diastolic velocity 40 cm/s, and an internal
carotid artery/common carotid artery ratio 2.
EST protocol. The EST was performed according to
the modified protocol of Bruce.12 A positive test was de-
fined as a decrease in the ST segment of at least 1 mm
measured at 80 ms from the J point.
Statistical analyses. The quantitative variables are
presented as means with standard deviation and the quali-
tative variables are presented as percentages. Comparisons
between the quantitative variables were with the Student t
test and between the qualitative variables were with the 2
test. The comparisons between cases (those with a patho-
logically low ABI) and control subject were with the Mc-
Nemar test. Logistic regression analyses were performed to
evaluate the independent contribution of the ABI and of
each of the cardiovascular risk factors to the risk of carotid
stenosis and of an abnormal EST. The software program
used for all statistical analyses was the SPSS package (ver-
sion 13.0; SPSS, Inc, Chicago, Ill).
All subjects gave written informed consent, and the
study was approved by the Committee on Ethics and
Research of the Hospital Carlos III in Madrid.
RESULTS
There were 1070 subjects included in the study (706 in
Madrid and 364 in Santiago de Compostela). The overall
mean ABI for the population sample was 1.06 (0.14),
ranging from 0.51 to 1.56. The overall prevalence of a low
ABI was 9.1%. A 1.5% of all participants have an ABI1.4.
parated by normal (n  973) or low (n  97)
0.9) 9.1% Normal ABI (0.9) 90.9% P
.6 52.7 .715
(6.7) 66.1 (6.8) .01
.2 24.4 .002
.6 62.6 .645
.2 34.7 .383
(4.6) 29.8 (4.4) .84
(19) 145 (19) .005
(13) 81 (10) .30
(.90) 3.56 (.91) .11
(.33) 1.37 (.33) .04
(.94) 1.45 (.85) .365
.4 49 .475
.3 37.3 .746
tein; LDL, low density lipoprotein; SBP, systolic blood pressure.0) se
BI (
54
69.3
40
64
39
29.7
151
80
3.72
1.30
1.53
53
35The characteristics of the population are presented in Table I.
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a higher prevalence of smoking habit. Also, they had a
lower concentration of HDL-cholesterol.
Of the 97 cases with an ABI0.9, 12 did not give their
consent to continue in the study. These individuals did not
differ from the rest of participants in relation to age, gender,
risk factors, and mean ABI values. The characteristics of the
85 subjects with a low ABI together with their correspond-
ing 85 controls are presented in Table II. Both groups were
well matched with respect to age, gender, diabetes, and
smoking habit. There were no differences with respect to
other risk factors except that SBP was higher in cases.
Carotid ultrasound. Carotid plaques were present in
53.6% of the cases compared to 43.5% of the controls. The
prevalence of a stenosis 50% was 14.3%  5.9% in cases
and 4.7% 2.3% in controls (Odds Ratio [OR]: 3.37; 95%
Confidence Interval [CI]: 1.04-10.93, P  .033). There
was only one individual case with stenosis 70%. The
association between a low ABI and carotid stenosis lost its
significance in the multivariate analysis (OR: 2.5; 95% CI:
0.75-8.4) after adjusting for SBP and other cardiovascular
risk factors.
Considering only subjects with a low ABI, those with a
stenosis 50% were more frequently women, older, active
smokers, hypertensives, and with higher mean concentra-
tions of LDL-cholesterol and plasma triglycerides (Fig 1).
Exercise stress test. The EST was valid in 75 subjects.
In 10, there were basal alterations either in the ST segment
or a left bundle branch block (five cases), failure to reach
sub-maximum heart rate (three cases), or problems with
the adaptation to the treadmill (two cases). The prevalence
of a positive EST was 16.2%  4.2% in cases and 10.5% 
3.5% in controls (OR: 1.65; 95% CI: 0.63-4.29, P .309).
Considering only subjects with a low ABI, the preva-
lence of a positive ESTwas higher in subjects with advanced
age, hypertension, and diabetes, and in those with high
Table II. Characteristics of cases (n  85) and control
subjects (n  85)
Characteristic Cases Controls P
Gender; % males 56.5 56.5 Matched
Age; years 70.1 (6.1) 69.9 (6.2) Matched
Smokers or ex-smokers; % 38.8 38.8 Matched
Diabetes; % 36.5 36.5 Matched
BMI; kg/m2 29.3 (4.5) 29.3 (4.3) .865
Hypertension; % 67.9 64.7 .665
SBP; mmHg 152 (18) 142 (19) .0001
DBP; mmHg 80 (13) 79 (9) .841
LDL-cholesterol; mmol/L 3.79 (.92) 3.72 (.90) .318
HDL-cholesterol; mmol/L 1.33 (.33) 1.32 (.32) .958
Triglycerides; mmol/L 1.58 (1.0) 1.44 (.66) .23
BP lowering drugs; % 55.7 45.8 .175
Lipid lowering drugs; % 34.5 26.2 .327
ABI 0.78 (0.11) 1.10 (0.11) .0001
ABI, ankle-brachial index; BMI, body mass index; BP, blood pressure;DBP,
diastolic blood pressure; HDL, high density lipoprotein; LDL, low density
lipoprotein; SBP, systolic blood pressure.triglycerides or low HDL-cholesterol (Fig 2).DISCUSSION
Our results showed that subjects60 years of age with
a low ABI and without known vascular disease have a
prevalence of carotid stenosis three-fold greater, and of
silent myocardial ischaemia 1.6-fold greater, albeit statisti-
cally non-significant, than subjects with a normal ABI.
Carotid stenosis was present in 14.3% of patients, a percent-
age that was greater in women, in smokers, in subjects with
advanced age, in those with hypertension, and in those with
elevated levels of triglycerides or LDL-cholesterol. Simi-
larly, the prevalence of silent myocardial ischaemia was
higher in subjects with hypertension, diabetes, advanced
age, high triglyceride, or low HDL-cholesterol concentra-
tions.
The prevalence of carotid stenosis and of silent myocar-
dial ischemia found in our study can be used to estimate the
efficiency of searching for occult vascular disease in this
population. The results are relevant given that ABI is being
increasingly used in primary-care health centers as well as in
specialized outpatient clinics for improving the stratifica-
tion of cardiovascular disease risk.2
The prevalence of a carotid stenosis 50% ranges be-
tween 2% and 11% depending on the characteristics of the
population studied,13-15 and is higher, between 14% and
Fig 1. Prevalence of carotid stenosis in subjects with asymptom-
atic PAD and according to the presence of additional cardiovascu-
lar risk factors.
Fig 2. Prevalence of an abnormal exercise stress test in subjects
with asymptomatic PAD and according to the presence of addi-
tional cardiovascular risk factors.36%, in patients with symptomatic PAD.4,16-20 The preva-
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range observed in patients with symptomatic disease. There
is considerable debate regarding the value of population
screening to detect the presence of asymptomatic carotid
stenosis, and whether there is a specific subgroup that can
benefit more from this strategy. The search for carotid
stenosis has been recommended in populations in which
the prevalence of stenosis60% is higher than 4.5% and in
which the annual rate of stroke is above 3.3% per year.21 For
this reason, several clinical guidelines recommend carotid
duplex scanning in patients with symptomatic PAD.5,7
Early detection of asymptomatic carotid stenosis is impor-
tant for the identification of potential candidates for carotid
endarterectomy and in order to select a group of subjects
amenable to follow-up and evaluation of disease progres-
sion.
The association between a low ABI and carotid stenosis
was reduced and lost its significance in multivariate analysis
after adjusting for systolic blood pressure. Both PAD and
carotid stenosis have been associated with hyperten-
sion22,23 and this and other risk factors could be partially or
totally responsible for this association.
The prevalence of a positive EST was 16%. The preva-
lence of myocardial ischemia in the general population
depends on the techniques and the criteria employed, the
age of the population evaluated, and the co-existence of
cardiovascular risk factors. In subjects with symptomatic
PAD and without clinical coronary disease, this prevalence
is about 18% with Holter monitoring24 and reaches 57%
when thallium dipyridamol scintigraphy is used.25 In pa-
tients with diabetes, the presence of PAD is the best pre-
dictive factor of a myocardial perfusion defect.26,27 Also,
subjects with a low ABI have a greater risk of segmental wall
motion abnormalities, as measured by echocardiography.22
Despite this, the low sensitivity and specificity of the EST
brings its usefulness into question. Generally, it is not recom-
mended in asymptomatic subjects with a low pre-test proba-
bility, although it could provide valuable prognostic informa-
tion in high risk subjects, such as patients with PAD.28
Our results indicate that in asymptomatic high-risk
subjects 60 years of age and with an ABI 0.9, there
needs to be between five and 12 duplex carotid scans and
between five and eight EST performed to detect an abnor-
mal clinically-relevant result. These numbers are less if
subjects with a higher risk profile are selected (ie, those of
more advanced age, with diabetes, or hypertension).
Our study has certain limitations. It is necessary to have
available a considerable number of subjects free of cardio-
vascular disease to be able to detect a sufficient number of
them with an abnormal ABI. As such, our sample size may
be considered limited, which precludes a more precise
estimation of the prevalence of carotid stenosis and silent
myocardial ischemia in patients with asymptomatic PAD. A
further limitation is not having performed additional tests
in the subjects with a positive EST, which precludes us
knowing the real prevalence of coronary artery disease in
these subjects.We conclude that, in subjects between 60 and 80 years
of age and without clinical cardiovascular disease, the pres-
ence of an ABI 0.9 identifies a subgroup of the popula-
tion with an elevated prevalence of asymptomatic carotid
stenosis and of silent myocardial ischaemia. This prevalence
is further elevated in those with advanced age, and in those
with diabetes or hypertension.
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